Wealth Alliance’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,082
Closed -$228K 524
2023
Q4
$228K Sell
3,082
-350
-10% -$22.9K 0.03% 457
2023
Q3
$234K Sell
3,432
-898
-21% -$76.2K 0.04% 424
2023
Q2
$407K Buy
4,330
+1,125
+35% +$87.8K 0.06% 289
2023
Q1
$217K Buy
+3,205
New +$206K 0.04% 460
2021
Q3
Sell
-2,079
Closed -$258K 437
2021
Q2
$258K Buy
2,079
+526
+34% +$62.8K 0.06% 362
2021
Q1
$205K Sell
1,553
-1,074
-41% -$147K 0.06% 369
2020
Q4
$348K Buy
2,627
+412
+19% +$49.8K 0.1% 251
2020
Q3
$226K Sell
2,215
-190
-8% -$16.4K 0.08% 289
2020
Q2
$209K Buy
+2,405
New +$192K 0.08% 286

Other funds holding EXAS

Wealth Alliance's EXAS Position: Q1 2024 in Review

Wealth Alliance sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 3,082 shares — an estimated $228K sold.

Wealth Alliance first reported a position in EXAS in Q2 2020 and held it in 9 quarters. The position peaked at $407K in Q2 2023. 626 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Wealth Alliance reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Wealth Alliance sold 3,082 Exact Sciences shares in Q1 2024, an estimated $228K.
  • Wealth Alliance first reported a position in Exact Sciences in Q2 2020 and held it in 9 quarters.
  • Wealth Alliance's Exact Sciences position peaked at $407K in Q2 2023.
  • 626 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Wealth Alliance's 13F filing for Q1 2024, filed 10 May 2024.